文献速递妇科

高内脏脂肪与皮下脂肪比值预示晚期子宫内膜癌患者预后不良

High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2022-09-28

该回顾性研究纳入2004至2014年间接受手术的83例III-IV期子宫内膜癌患者,通过术前CT测量内脏脂肪(VAT)、皮下脂肪(SAT)及总脂肪(TAT),探索性分析确定预后不良体成分的最佳截断值。VAT/SAT比值高(>0.45)组相比低比值(<0.45)组,无复发生存期(中位29.6 vs 32.3个月,P=0.01)和总生存期(中位56 vs 93.7个月,P=0.03)均更短。结论认为内脏脂肪测量可预测晚期子宫内膜癌结局,VAT/SAT比值可预测总生存。

要点

  • VAT/SAT比值高(>0.45)组无复发生存期较比值低(<0.45)组更短(中位29.6 vs 32.3个月,P=0.01)。
  • VAT/SAT比值高(>0.45)组总生存期较比值低(<0.45)组更短(中位56 vs 93.7个月,P=0.03)。
  • VAT/SAT比值是晚期子宫内膜癌总生存的预测指标。

核心结论

  • 内脏脂肪测量可预测晚期子宫内膜癌患者的结局,VAT/SAT比值可预测总生存。
  • 未来应开展研究以识别肥胖与子宫内膜癌关系背后的潜在治疗靶点和生物学机制。

研究设计与样本

  • 回顾性综述,纳入2004至2014年间接受手术的III-IV期子宫内膜癌患者83例。
  • 通过术前计算机断层扫描(CT)评估内脏脂肪组织(VAT)、皮下脂肪组织(SAT)和总脂肪组织(TAT;VAT+SAT)。
  • 进行探索性分析以确定VAT、SAT和TAT识别预后不良体成分的最佳截断值。
  • 采用Kaplan-Meier分析、对数秩检验和Cox回归分析生存率。

主要发现

  • 42例(51%)患者VAT/SAT比值低(<0.45),41例(49.4%)患者VAT/SAT比值高(>0.45)。
  • 两组间人口统计学特征无显著差异。
  • VAT、SAT和TAT的平均值分别为176.3 cm²、379.3 cm²和555.3 cm²。
  • 相比VAT/SAT比值低的患者,VAT/SAT比值高的患者无复发生存期更短(中位29.6 vs 32.3个月,P=0.01)。
  • 相比VAT/SAT比值低的患者,VAT/SAT比值高的患者总生存期更短(中位56 vs 93.7个月,P=0.03)。

关键数值与推荐

  • VAT/SAT比值低定义为<0.45。
  • VAT/SAT比值高定义为>0.45。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Visceral adiposity has been established as a predictor of outcomes in various cancers. We aimed to determine the association of radiographic measurements of visceral fat with clinical outcomes in patients with endometrial cancer. METHODS: A retrospective review of patients with stage III-IV endometrial cancer who underwent surgery between 2004 and 2014 was performed. Visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and total adipose tissue (TAT;VAT+SAT) were assessed on preoperative computed tomography (CT) scans. Exploratory analysis was performed to establish the optimal cut-off values for VAT, SAT, and TAT to identify patients with poor prognostic body composition. Survival rates were analyzed using Kaplan-Meier analysis, log-rank tests, and cox-regression. RESULTS: Eighty-three patients were included. Forty-two (51%) patients had a low VAT/SAT ratio (<0.45) and 41 (49.4%) had a high VAT/SAT ratio (>0.45). There were no significant differences in demographics between the groups. The mean VAT, SAT, and TAT were 176.3 cm2, 379.3 cm2, and 555.3 cm2 respectively. Compared to patients with low VAT/SAT ratios, patients with high VAT/SAT ratios had a shorter recurrence-free survival (median 29.6 vs 32.3 months, P = 0.01) and shorter overall survival (median 56 vs 93.7 months, P = 0.03). CONCLUSIONS: Visceral fat measurements are predictive of outcomes in patients with advanced stage endometrial cancer. Specifically, VAT to SAT ratios are predictive of overall survival. Future studies should be pursued to identify potential therapeutic targets and biological mechanisms that underlie obesity's relationship with endometrial cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Buckley E, Mullen MM, Nizamuddin RA, et al. High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer. Gynecol Oncol. 2022. PMID: 36180305. doi:10.1016/j.ygyno.2022.09.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。